stancaris wrote:Competing companies certainly want to play down the importance of the X chromosome while at the same time pushing their own agendas which involve research on autosomes. They certainly would not want to discover any major variants on the X chromosome because that would only give another boost to the already great amount of interest in the so called superlative X.
That's almost as absurd as the idea that the "best" of Buckpasser's X can "somehow" be passed along through one of his sons. (Why let biological fact get in the way of what you want to believe?)
No one studying the TB genome in the academic and/or commercial sectors regards Haun as a competitor. I dare say many of them outside North America have probably never heard of her or her hypothesis and they're certainly not going to ignore genetic variants of more than minor relevance to superior performance, wherever they may be.